ReWalk Robotics Ltd. (NASDAQ:RWLK) shares saw strong trading volume on Tuesday . 299,208 shares traded hands during trading, an increase of 234% from the previous session’s volume of 89,575 shares.The stock last traded at $6.56 and had previously closed at $6.47.

Several research analysts have recently weighed in on the company. Canaccord Genuity restated a “buy” rating on shares of ReWalk Robotics in a report on Sunday. Piper Jaffray Cos. started coverage on shares of ReWalk Robotics in a research report on Friday, July 15th. They set an “overweight” rating and a $10.00 price target on the stock. Zacks Investment Research lowered shares of ReWalk Robotics from a “buy” rating to a “hold” rating in a research report on Thursday, July 7th. Finally, Jefferies Group reaffirmed a “buy” rating and set a $16.00 price target on shares of ReWalk Robotics in a research report on Sunday, May 8th. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. ReWalk Robotics has a consensus rating of “Buy” and an average target price of $12.80.

The company’s 50 day moving average is $6.69 and its 200-day moving average is $8.49. The stock’s market cap is $83.26 million.

ReWalk Robotics (NASDAQ:RWLK) last issued its earnings results on Thursday, August 4th. The medical device company reported ($0.64) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.53) by $0.11. The business had revenue of $0.82 million for the quarter, compared to the consensus estimate of $1.95 million. ReWalk Robotics’s revenue was up 34.4% compared to the same quarter last year. On average, equities research analysts forecast that ReWalk Robotics Ltd. will post ($2.18) earnings per share for the current year.

In other news, major shareholder Scp Vitalife Partners (Israel) sold 4,772 shares of the stock in a transaction that occurred on Friday, June 3rd. The shares were sold at an average price of $7.89, for a total value of $37,651.08. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Jeff Dykan sold 11,370 shares of the stock in a transaction that occurred on Wednesday, June 1st. The shares were sold at an average price of $7.74, for a total transaction of $88,003.80. The disclosure for this sale can be found here.

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk. The Company offers ReWalk, an exoskeleton that uses its tilt-sensor technology, and an on-board computer and motion sensors to drive motorized legs that power movement.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.